Company
Product List
Offer to buy
Offer to sell
Sign In
Join
Help
Languages
English
繁體中文
簡體中文
Changchun Changsheng Life Sciences Ltd.
Home
Company Profile
Products
Video
Inquiry
Contact Us
Recommended Results
Lyophilized Hepatitis A vaccine
Category :
Chemicals->Chemical->aspalthic products
View Larger Picture
View Larger Picture
View Larger Picture
Product Specification
Model No:
1.0mL/Vial
Country
CN
Brand
Wanxin
Minimum Order
5000
Payment Term
L/C,T/T
Product Detail
<p class="MsoNormal">
<p class="MsoNormal">
<b>[Drug name]</b><b></b>
</p>
<p class="MsoNormal">
Adopted name: Hepatitis A ( Live) Vaccine, Freeze-dried
</p>
<p class="MsoNormal">
<b>[Description]</b><b></b>
</p>
<p class="MsoNormal">
The freeze-dried hepatitis A vaccine is a preparation made from the live attenuated strain of hepatitis A virus (HAV) grown in human diploid cell cultures. After cultivation, harvest and extraction of the virus, the virus suspension is lyophilized after adding an appropriate srabilizer to make the vaccine. It looks like a milky-white crisp cake and it turns into a clear liquid after reconstitution.
</p>
<p class="MsoNormal">
Active constituent: live attenuated Hepatitis A virus.
</p>
<p class="MsoNormal">
Subsidiary materials: All the components of subsidiary materials approved shall be listed.
</p>
<p class="MsoNormal">
Diluent: sterile water for injection.
</p>
<p class="MsoNormal">
<b>[Eligibles]</b><b></b>
</p>
<p class="MsoNormal">
Hepatitis A - susceptible individuals above one and a half years of age.
</p>
<p class="MsoNormal">
<b>[Action and use]</b><b></b>
</p>
<p class="MsoNormal">
The product can induce immunity against hepatitis . A virus in recipients following immunization. It is used to prevent hepatitis A.
</p>
<p class="MsoNormal">
<b>[Specifications]</b><b></b>
</p>
<p class="MsoNormal">
0. 5 ml or l. 0 ml of reconstituted vaccine per container. 0. 5 ml or l. 0 ml per single human dose containing not less than 6.50 lg CCID<sub>50</sub> of live hepatitis A virus.
</p>
<p class="MsoNormal">
<b>[Administration and dosage]</b><b></b>
</p>
<p class="MsoNormal">
Reconstitute the vaccine with sterile water for injection as the stated value. Shake the container till the content is reconstituted completely before use. Inject s. c. a single human dose of the reconstituted vaccine at deltoid insertion area of the lateral upper arm.
</p>
<p class="MsoNormal">
<b>[Adverse reactions]</b><b></b>
</p>
<p class="MsoNormal">
(1) Pain and tenderness may occur at the injection site generally within 24 hours after vaccination, which can be relieved spontaneously within 2-3 days in most cases.
</p>
<p class="MsoNormal">
(2) Transient fever may occur generally within l-2 weeks after vaccination, most of which are mild . and can be relieved spontaneously within l-2 days and need no particular treatment. If necessary, the recipients should have an appropriate rest and drink more hot water. Care should be taken to keep warm for the prevention of secondary infections. The recipients with moderate fever or with the fever lasting for more than 48 hours may receive physical therapy or symptomatic treatment.
</p>
<p class="MsoNormal">
(3) Occasionally, sporadic rash may occur after vaccination and commonly no particular treatment is needed. In case of necessity, symptomatic treatment might be helpful.
</p>
<p class="MsoNormal">
Rare adverse reactions :
</p>
<p class="MsoNormal">
Severe fever: Physical therapy and symptomatic treatment shall be adopted to prevent febrile convulsion.
</p>
<p class="MsoNormal">
Extremely rare adverse reactions :
</p>
<p class="MsoNormal">
(l) Anaphylactic shock: Anaphylactic shock may occur within one hour after vaccination, emergency measures shall be adopted immediately including prompt injection of adrenaline.
</p>
<p class="MsoNormal">
(2) Allergic rash: Urticaria may occur generally within 72 hours after vaccination, if it occurs the recipients shall go to the clinic promptly and receive anti-anaphylactic treatment.
</p>
<p class="MsoNormal">
(3) Allergic purpura: The recipients with allergic purpura shall go to the clinic promptly and receive anti-anaphylactic treatment with corticosteroid. If the treatment is inappropriate or delayed, purpuric nephritis may be complicated.
</p>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<span><strong>[</strong></span><strong>Function and use</strong><span><strong>]</strong></span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
The product can induce immunity against hepatitis A virus in recipients following immunization. It is used to prevent hepatitis A.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<span><strong>[</strong></span><strong>Description</strong><span><strong>]</strong></span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
The freeze-dried hepatitis A vaccine is a preparation made from the live attenuated strain of hepatitis A virus (HAV) grown in human diploid cell cultures. After cultivation, harvest and extraction of the virus, the virus suspension is lyophilized after adding an appropriate stabilizer to make the vaccine. It looks like a milky-white crisp cake and it turns into a clear liquid after reconstitution.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
Active constituent: live attenuated Hepatitis A virus.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
Subsidiary materials: All the components of subsidiary materials approved shall be listed.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
Diluent: sterile water for injection.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<span>[</span>Specifications<span>]</span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
1.0 ml of reconstituted vaccine per container. 1.0 ml per single human dose containing not less than 6.50lg CCID50 of live hepatitis A virus.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<span><strong>[</strong></span><strong>Feature</strong><span><strong>]</strong></span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
Advantages: 1.Accordance with the trend of biomedicine.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
2. Convenient for storage and transportation.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
3. The improvement of the stability of the vaccine,30-months of self life.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
4. The extension of the validation.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
5. More stable immune results
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
Results from the study group of National 95 Key Task Project:
</p>
<p class="MsoNormal" style="margin-left:21.0000pt;text-indent:-21.0000pt;text-align:justify;" align="justify">
100% safety for injection of live hepatitis A vaccine,freeze-dried
</p>
<p class="MsoNormal" style="margin-left:21.0000pt;text-indent:-21.0000pt;text-align:justify;" align="justify">
100% seroconversion rate after 2 dose injection
</p>
<p class="MsoNormal" style="margin-left:21.0000pt;text-indent:-21.0000pt;text-align:justify;" align="justify">
100% epidemiologic protective efficacy
</p>
<p class="MsoNormal" style="margin-left:21.0000pt;text-indent:-21.0000pt;text-align:justify;" align="justify">
lAll of the products passed the national quality control
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<br />
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<img src="http://i.bosscdn.com/product/93/61/43/ae17fe3a5e771957f18c1367d2.jpg@watermark=2&color=I0ZGRkZGRg%3D%3D&type=ZHJvaWRzYW5zZmFsbGJhY2s%3D&size=22&p=9&t=80&text=Y3MtdmFjY2luZS5ib3NzZ29vLmNvbQ%3D%3D" title="HAV" alt="HAV" />
</p>
<p>
<br />
</p>
<p>
<br />
</p>
<p class="MsoNormal">
<br />
</p>ccls-vaccine.com
More Products from this Supplier
Bulk Rabies Vaccine For Human Use
Vaccinate Influenza Vaccine For Human
Clinical Rabies Vaccine For Human Use
Group A and C Meningococcal Polysaccharide Vaccine
[ Back Products Catalog ]
Commerce Member:
Please log in your ID and password, we will later fill in relating info.
ID:
Password:
Remember my ID on this computer
Complete this form below to send out your enquiries.
All enquiries will be automatically sent to the company you want to develop.
Subject
Content
(Don't input Company Name, E-Mail, Phone Number, Fax Number, and URL)
Company Profile:
*
Company Name
*
E-mail
*
Country
Please Select Your Country
United States
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaidjan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
Former Czechoslovakia
Former USSR
France
France (European Territory)
French Guyana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Great Britain
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guinea
Guinea Bissau
Guyana
Haiti
Heard and McDonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldavia
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
Neutral Zone
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion (French)
Romania
Russian Federation
Rwanda
S. Georgia & S. Sandwich Isls.
Saint Helena
Saint Kitts & Nevis Anguilla
Saint Lucia
Saint Pierre and Miquelon
Saint Tome (Sao Tome) and Principe
Saint Vincent & Grenadines
Samoa
San Marino
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovak Republic
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Tajikistan
Taiwan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vanuatu
Vatican City State
Venezuela
Vietnam
Virgin Islands (British)
Virgin Islands (USA)
Wallis and Futuna Islands
Western Sahara
Yemen
Yugoslavia
Zaire
Zambia
Zimbabwe
*
Contact Person
URL
*
Phone
-
-
Fax
-
-
*
Postal code
*
City
*
Street Address
*
Business Nature
Distributor
Exporter
Importer
Manufacturer
Whole Sale
Retailer
Reseller
Retrofitter
User
Others, please specify:
*
Security Code
Enter the security code.
Site Map l
Privacy Policy l
Company Profile l
Corporate Proposal l
Contact Us l
Help l
Advertise With Us l
World Trade Link
.